NCT00001443View on ClinicalTrials.gov

A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 1995

Study Completion Date

October 31, 2000

Conditions
Acquired Immunodeficiency SyndromeHIV Infections
Interventions
DRUG

indinavir (MK-0639)

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001443 - A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection | Biotech Hunter | Biotech Hunter